Ultrasensitive bioorthogonal probes for selective discrimination of trace H2S2/H2S n in sulfide-competitive contexts.

Acta Pharm Sin B · 2026 · PMC13366304 · PMID 42453409

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

For example, they are markedly elevated in inflammatory conditions and type 2 diabetes, whereas they exhibit a decreasing trend in liver injury models.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Ultrasensitive bioorthogonal probes for selective discrimination of trace H&lt;sub&gt;2&lt;/sub&gt;S&lt;sub&gt;2&lt;/sub&gt;/H&lt;sub&gt;2&lt;/sub&gt;S &lt;sub&gt;&lt;i&gt;n&lt;/i&gt;&lt;/sub&gt; in sulfide-competitive contexts.

The sentences

Ultrasensitive bioorthogonal probes for selective discrimination of trace H<sub>2</sub>S<sub>2</sub>/H<sub>2</sub>S <sub><i>n</i></sub> in sulfide-competitive contexts.